FindTrial
Sign In

A study to find out the effect of Covid Vaccine in patients living with HIV/AIDS in central Kerala and to identify different types of SARS CoV2 viruses affecting these patients

Effectiveness of Covid Vaccine and identification of SARS CoV2 Variants among PLHIV in Central Kerala â?? An Ambi-directional Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037337
Enrollment
910
Registered
2021-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B20- Human immunodeficiency virus [HIV]disease

Interventions

Control Intervention1: NIL: NIL

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PLHIV above 18 years of age

Exclusion criteria

Exclusion criteria: Any participant not able to communicate coherently or is non-ambulatory (mentally ill, dementic, bedridden, unconscious & comatose)

Design outcomes

Primary

MeasureTime frame
Vaccine effectiveness of COVID-19 vaccines among PLHIVTimepoint: 12 months—

Secondary

MeasureTime frame
1) Cut off value of CD4 count that could predict severity of COVID-19 in PLHIV 2)Proportion of different SARS CoV-2 variants infecting PLHI Timepoint: 12 months—

Countries

India

Contacts

Public ContactJoe Thomas

Jubilee Mission Medical College and Research Institute Thrissur

covidjmmcri@gmail.com9447960010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026